The Scientific Committee begins accepting abstracts and applications for the scientific program of the XI International Forum of Cardiology and Internal Medicine

Detailed information is provided in the information letter.

Tirzepatide Cuts BP During Obesity Treatment CHICAGO — Treatment with the "twincretin" tirzepatide led to significant and potentially clinically meaningful cuts in 24-hour ambulatory blood pressure, compared with placebo, while causing modest increases in heart rate, in a prespecified substudy of the SURMOUNT-1 trial.

Preeclampsia Linked to Increased Risk for Heart Disease, Stroke in Offspring Preeclampsia is a major cause of maternal and perinatal morbidity and mortality, affecting as many as 5% of pregnancies worldwide. New evidence suggests that the complication doesn't end with delivery.

Four-Drug Combo Gets BP Down in One Step: QUARTET-USA Use of a combination antihypertensive product containing quarter doses of four different drugs could be an effective strategy to get patients to target blood pressures in one step, a new study suggests.

AI eye checks can predict heart disease risk in less than minute, finds study Breakthrough opens door to a highly effective, non-invasive test that does not need to be done in a clinic. An artificial intelligence tool that scans eyes can accurately predict a person’s risk of heart disease in less than a minute, researchers say.

ACC Issues Guidance on ED Evaluation of Acute Chest Pain The American College of Cardiology (ACC) has released an Expert Consensus Decision Pathway (ECDP) on the evaluation and disposition of acute chest pain in the emergency department (ED). Chest pain accounts for more than 7 million ED visits annually. A major challenge is to quickly identify the small number of patients with acute coronary syndrome (ACS) among the large number of patients who have noncardiac conditions.

CARDIOPROGRESS
Foundation for the advancement of cardiology